Luai Zarour

902 total citations
9 papers, 353 citations indexed

About

Luai Zarour is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Luai Zarour has authored 9 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Hepatology. Recurrent topics in Luai Zarour's work include Pancreatic and Hepatic Oncology Research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer Cells and Metastasis (3 papers). Luai Zarour is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer Cells and Metastasis (3 papers). Luai Zarour collaborates with scholars based in United States, Austria and India. Luai Zarour's co-authors include Melissa H. Wong, Charles E. Gast, Skye C. Mayo, Vassiliki L. Tsikitis, Charles D. Lopez, Kevin G. Billingsley, Rebecca Ruhl, Lissi Hansen, Katherine A. Kelley and Lisa M. Coussens and has published in prestigious journals such as Developmental Cell, The American Journal of Surgery and Annals of Surgical Oncology.

In The Last Decade

Luai Zarour

9 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luai Zarour United States 6 153 128 85 72 65 9 353
Bao‐Ye Sun China 12 104 0.7× 169 1.3× 136 1.6× 77 1.1× 70 1.1× 22 370
Ranjan Prasad Devbhandari China 7 91 0.6× 231 1.8× 152 1.8× 48 0.7× 47 0.7× 10 457
Agnes Csiszar Austria 8 227 1.5× 205 1.6× 92 1.1× 108 1.5× 58 0.9× 12 428
Carlotta Raschioni Italy 9 201 1.3× 284 2.2× 158 1.9× 141 2.0× 48 0.7× 11 566
Charles P. Xavier United States 8 71 0.5× 292 2.3× 55 0.6× 59 0.8× 35 0.5× 12 396
Jittiporn Chaisaingmongkol Thailand 10 138 0.9× 227 1.8× 134 1.6× 134 1.9× 32 0.5× 13 419
Laura Ogle United Kingdom 8 165 1.1× 115 0.9× 107 1.3× 39 0.5× 103 1.6× 10 332
Anja Hohmeyer Germany 3 122 0.8× 234 1.8× 79 0.9× 91 1.3× 55 0.8× 3 390
Fubo Ji China 5 83 0.5× 196 1.5× 95 1.1× 76 1.1× 35 0.5× 11 355
Lai Chun Ong Singapore 5 297 1.9× 171 1.3× 100 1.2× 173 2.4× 18 0.3× 5 546

Countries citing papers authored by Luai Zarour

Since Specialization
Citations

This map shows the geographic impact of Luai Zarour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luai Zarour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luai Zarour more than expected).

Fields of papers citing papers by Luai Zarour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luai Zarour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luai Zarour. The network helps show where Luai Zarour may publish in the future.

Co-authorship network of co-authors of Luai Zarour

This figure shows the co-authorship network connecting the top 25 collaborators of Luai Zarour. A scholar is included among the top collaborators of Luai Zarour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luai Zarour. Luai Zarour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Walker, Brett S., Thomas L. Sutton, Luai Zarour, et al.. (2021). Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal Cancers. Annals of Surgical Oncology. 28(13). 8567–8578. 16 indexed citations
2.
Walker, Brandon S., Kevin G. Billingsley, Thomas L. Sutton, et al.. (2020). Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program. HPB. 22. S123–S124. 2 indexed citations
3.
Walker, Brett S., Luai Zarour, John Swain, et al.. (2020). Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia. World Journal of Surgery. 44(10). 3501–3509. 5 indexed citations
4.
Zarour, Luai, Kevin G. Billingsley, Brett S. Walker, et al.. (2019). Hepatic resection of solitary HCC in the elderly: A unique disease in a growing population. The American Journal of Surgery. 217(5). 899–905. 10 indexed citations
5.
Zarour, Luai, John Swain, Kevin G. Billingsley, et al.. (2018). Use of circulating cancer cell hybrids to monitor treatment response to hepatic arterial infusion in patients with colorectal cancer metastatic to the liver. HPB. 20. S352–S352. 1 indexed citations
6.
Zarour, Luai, Sudarshan Anand, Kevin G. Billingsley, et al.. (2017). Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions. Cellular and Molecular Gastroenterology and Hepatology. 3(2). 163–173. 198 indexed citations
7.
Roh‐Johnson, Minna, Arish N Shah, Julia Kargl, et al.. (2017). Macrophage-Dependent Cytoplasmic Transfer during Melanoma Invasion In Vivo. Developmental Cell. 43(5). 549–562.e6. 88 indexed citations
8.
Schwartzman, Jacob, Solange Mongoue‐Tchokote, Angela Gibbs, et al.. (2011). A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer. Epigenetics. 6(10). 1248–1256. 15 indexed citations
9.
Zarour, Luai & Joshi J. Alumkal. (2010). Emerging Therapies in Castrate-Resistant Prostate Cancer. Current Urology Reports. 11(3). 152–158. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026